Has Sharmin Nabi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $396 in general payments to Sharmin Nabi, MD across 16 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sharmin Nabi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sharmin Nabi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sharmin Nabi, MD

Psychiatry · Mission Viejo, CANPI 1164050597

Payments from drug & device makers

$396in general payments, 2019–2025

Across 16 payments — averaging $24.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Vanda Pharmaceuticals Inc.$95
Biogen$81
Alkermes, Inc.$45
AbbVie$35
E.r. Squibb & Sons, L.L.C.$34
Lundbeck LLC$34
plus $72 from 3 others

What the payments were for

Food & beverage$396100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Vanda Pharmaceuticals Inc.	3	$95
Biogen	3	$81
Alkermes, Inc.	2	$45
AbbVie	2	$35
E.r. Squibb & Sons, L.L.C.	1	$34
Lundbeck LLC	1	$34
Takeda Pharmaceuticals U.S.A., Inc.	2	$29
Neurocrine Biosciences, Inc.	1	$29
Teva Pharmaceuticals USA, Inc.	1	$14

How this compares

$396 in reported general payments places this provider in the 60th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California →

Medicare billing

Part B allowed, 2024

$10,676

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Aripiprazole	42	$3,598
Clozapine	12	$2,149
Hydroxyzine Hcl	41	$1,051
Mirtazapine	19	$1,012
Quetiapine Fumarate	37	$688
Bupropion XlBupropion Hcl	27	$665
Duloxetine Hcl	25	$596
Venlafaxine Hcl ErVenlafaxine Hcl	21	$554
Trazodone Hcl	45	$429
Buspirone Hcl	30	$415
Lurasidone Hcl	13	$340
Fluoxetine Hcl	23	$274
Sertraline Hcl	22	$208
Benztropine Mesylate	11	$146
Lamotrigine	36	$132

Paid to pharmacies, not to this prescriber.

Other psychiatry in Mission Viejo

Elly LeeIrvine$49.8M
Daniel ChuehOrange$17.9M
Eric ChavezSan Diego$15.5M
Lara ShirikjianTorrance$12.6M
John DuffySanta Ana$12M
Marina BusselPlaya Vista$12M
Sherry SoefjeOceanside$11.9M
Steven MacinaHuntington Beach$11.1M
Wakelin McNeelRosemead$11M
Donald AndersonBanning$10.5M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →